NPAT/EPS down over 50% on FY17 is worse than I was expecting. I am at work and will read and review the report more later, from an initial glance the outlook looks good but this result is pretty terrible.
- Forums
- ASX - By Stock
- Ann: FY18 Full Year Results - Investor Presentation
NPAT/EPS down over 50% on FY17 is worse than I was expecting. I...
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GXL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online